Prof. Jiang Xiaoqing (姜小清) — Biliary Tract Cancer & Liver Transplant | Oriental Hospital Shanghai
In the field of biliary tract oncology in China, few names carry the weight of Prof. Jiang Xiaoqing (姜小清). As the Honorary Chair of the Biliary Tumor Committee of the Chinese Anti-Cancer Association (CACA) — the national professional body dedicated to advancing the diagnosis and treatment of biliary tract cancers — Prof. Jiang represents the pinnacle of institutional recognition in this field. With over 30 years of dedicated hepatobiliary surgery practice and a reputation that extends across China's oncology community, he is a physician whose involvement in a patient's care carries both clinical and symbolic significance.
Now serving as Honorary Director at Oriental Hospital Shanghai (Tongji University), Prof. Jiang continues to see patients and provide expert consultation, bringing his decades of accumulated expertise to bear on the most complex and challenging biliary tract cancer cases.
Specialty Focus
- Biliary tract cancer: comprehensive treatment of cholangiocarcinoma and gallbladder cancer
- Intrahepatic, hilar, and distal cholangiocarcinoma: surgical and multimodal management
- Gallbladder cancer: surgical resection and comprehensive treatment strategies
- Liver transplantation for biliary tract malignancies and end-stage liver disease
- Complex hepatobiliary surgery: major hepatectomy, biliary reconstruction, vascular resection
- Multidisciplinary comprehensive treatment of biliary-pancreatic malignancies
Academic & Clinical Titles
- Honorary Director, Department of Hepatobiliary Surgery, Oriental Hospital Shanghai (Tongji University)
- Honorary Chair (名誉主彻), Biliary Tumor Committee, Chinese Anti-Cancer Association (CACA)
- Over 30 years of clinical experience in hepatobiliary surgery with subspecialty focus on biliary tract malignancies
- One of China's most recognized authorities in biliary tract oncology
Honorary Chair of China's National Biliary Tumor Committee
The Biliary Tumor Committee of the Chinese Anti-Cancer Association is the national professional organization responsible for advancing the diagnosis, treatment, and research of biliary tract cancers in China. The Honorary Chair designation — awarded to Prof. Jiang Xiaoqing — is the highest recognition the committee bestows, reserved for individuals who have made foundational contributions to the field over the course of a career.
For international patients, this designation carries important practical meaning. It signals that Prof. Jiang's clinical judgment and treatment philosophy have shaped how biliary tract cancers are managed across China — that the national guidelines and standards his colleagues follow reflect, in part, his decades of clinical experience and research. When Prof. Jiang evaluates a patient's case, he brings not just personal expertise but the accumulated wisdom of a career spent at the center of China's biliary oncology community.
Thirty Years of Hepatobiliary Surgery: The Value of Experience
Biliary tract surgery is among the most technically demanding subspecialties in abdominal surgery. The biliary system's intimate relationship with the portal vein, hepatic artery, and liver parenchyma means that operations for cholangiocarcinoma and gallbladder cancer frequently require simultaneous management of vascular, hepatic, and biliary structures — a technical challenge that demands both surgical skill and deep anatomical knowledge.
Over 30 years of focused hepatobiliary surgery practice, Prof. Jiang has accumulated a breadth and depth of operative experience that is simply not replicable in a shorter career. He has operated on patients with every presentation and stage of biliary tract cancer, managed the full spectrum of intraoperative and postoperative complications, and developed the clinical judgment that comes only from sustained high-volume practice in a demanding subspecialty.
For patients with complex or unusual presentations — tumors involving major vascular structures, recurrent disease after prior surgery, biliary complications requiring reconstruction, or cases where multiple prior opinions have been inconclusive — Prof. Jiang's depth of experience is particularly valuable.
Liver Transplantation for Biliary Tract Malignancies
Prof. Jiang's expertise extends to liver transplantation — a treatment modality that plays a specific role in the management of selected biliary tract malignancies. For patients with hilar cholangiocarcinoma (perihilar CCA) that cannot be resected with adequate margins due to bilateral biliary involvement or vascular encasement, liver transplantation following neoadjuvant chemoradiation (the Mayo Clinic protocol) has demonstrated excellent outcomes in carefully selected patients at specialized centers.
Similarly, for patients with intrahepatic cholangiocarcinoma arising in the context of primary sclerosing cholangitis or other chronic liver diseases, transplantation may be considered in selected cases. Prof. Jiang's combined expertise in biliary surgery and liver transplantation positions him to evaluate patients for whom transplantation might be an option that other surgeons have not considered.
Comprehensive Treatment: Integrating Surgery with Systemic Therapy
Prof. Jiang's approach to biliary tract cancer reflects the evolution of the field from a purely surgical discipline to a comprehensive oncological specialty. Modern biliary tract cancer management integrates surgery with systemic chemotherapy, targeted therapy (for patients with actionable molecular alterations including FGFR2 fusions, IDH1 mutations, HER2 amplification, and BRAF mutations), immunotherapy (for MSI-H tumors), interventional radiology, and radiation therapy.
As a senior figure who has witnessed and contributed to this evolution, Prof. Jiang brings a perspective that encompasses both the surgical and systemic dimensions of biliary tract cancer care. His consultations address not only the surgical question — is this tumor resectable, and if so, how? — but the broader treatment strategy question: what is the optimal sequence and combination of modalities for this specific patient?
Who Should Consider Consulting Prof. Jiang Xiaoqing
- Patients with cholangiocarcinoma or gallbladder cancer seeking a senior expert second opinion
- Patients with complex or advanced biliary tract tumors involving vascular structures
- Patients who have received conflicting opinions about resectability and want a definitive assessment from a senior authority
- Patients with hilar cholangiocarcinoma being evaluated for liver transplantation eligibility
- Patients with recurrent biliary tract cancer after prior surgery
- Patients with primary sclerosing cholangitis and associated cholangiocarcinoma
- Families seeking the most authoritative available opinion on a difficult biliary tract cancer case
How CMCS Connects You with Prof. Jiang Xiaoqing
China Medical Concierge Shanghai (CMCS) facilitates access to Prof. Jiang Xiaoqing for international patients with biliary tract cancers and complex hepatobiliary conditions. Our team manages the full coordination process — from remote case review and medical record translation to appointment scheduling, interpretation, and in-hospital support.
To begin, patients or their families are encouraged to share available medical records including CT and/or MRI with biliary protocol, MRCP, PET-CT if available, pathology reports, molecular profiling results, tumor markers (CA 19-9, CEA, AFP), liver function tests, and complete prior treatment summaries. Prof. Jiang's team can conduct an initial remote assessment before any travel to Shanghai is required.
CMCS provides end-to-end support including:
- Medical record translation (English, Arabic, French, and other languages)
- Remote pre-consultation case review and resectability assessment
- Appointment coordination with Prof. Jiang Xiaoqing at Oriental Hospital Shanghai
- On-site interpretation during consultations
- Liver transplant eligibility assessment coordination
- Post-consultation summary and follow-up support
Contact CMCS to Connect with Prof. Jiang Xiaoqing
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS – China Medical Concierge Shanghai connects international patients with Shanghai's leading specialists. We are a health management company, not a hospital. All clinical decisions are made by the treating physician.
0 comentarios